Skip to results
Modify your search
NARROW
1-5 of 5
Authors: John Anderson
Sort by
Journal Article
MDB-66. HIGH-THROUGHPUT SMALL MOLECULE DRUG SCREENING, TRANSCRIPTOMICS AND INTEGRATIVE AI IDENTIFY TARGETABLE MYC-DEPENDENT THERAPEUTIC VULNERABILITIES IN HIGH-RISK MEDULLOBLASTOMA Open Access
Gemma Llargués-Sistac and others
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.515
Published: 18 June 2024
Journal Article
ATRT-20. Novel prognostic molecular signatures for improved risk-classification of Atypical Teratoid Rhabdoid Tumours Open Access
Claire Keeling and others
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Page i7, https://doi.org/10.1093/neuonc/noac079.019
Published: 03 June 2022
Journal Article
EDITOR'S CHOICE
Phase II trial of hippocampal-sparing whole brain irradiation with simultaneous integrated boost for metastatic cancer Free
Kenneth D Westover and others
Neuro-Oncology, Volume 22, Issue 12, December 2020, Pages 1831–1839, https://doi.org/10.1093/neuonc/noaa092
Published: 29 April 2020
Journal Article
ATRT-20. INTRA- AND EXTRA-CRANIAL MALIGNANT RHABDOID TUMOURS SHARE COMMON LOCATION-INDEPENDENT CLINICAL AND MOLECULAR DISEASE CHARACTERISTICS Free
Yura Grabovska and others
Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Pages i31–i32, https://doi.org/10.1093/neuonc/noy059.018
Published: 22 June 2018
Journal Article
PP05. CHARACTERISATION OF DAXX IN THE DEPOSITION OF H3.3 IN PAEDIATRIC GLIOMA Free
Mr Mickey Lewis and others
Neuro-Oncology, Volume 19, Issue suppl_1, January 2017, Page i2, https://doi.org/10.1093/neuonc/now293.004
Published: 02 March 2017
Advertisement
Advertisement